Inflammatory bowel disease (IBD) is a wide range of conditions involving persistent inflammation of the digestive system. This analysis looks at the severity of IBD diseases such as Crohn’s disease and ulcerative colitis. It is an observational prospective research. The findings of this investigation are analyzed using R-programming. To compare the patient’s knowledge between the control and educational groups, as well as their effectiveness, R was used. The IBD has been revealed in recent papers. Food insecurity and a lack of social support affect one out of every eight individuals with inflammatory bowel disease. With socio-demographic data and R, there is a link between eating habits and kinds of food habits. The patients’ knowledge was analyzed and it is similar in the control group and educational group.

IBD, control group, educational group, socio-demographic, R‑programming.

Received: October 11, 2021; Accepted: November 25, 2021; Published: January 31, 2022

How to cite this article: J. Vennila, P. Basker, K. Thenmozhi, K. Rajeswari and P. Nithyakala, Analyzing the impact of inflammatory bowel disease (IBD) by using R-programming, JP Journal of Biostatistics 19 (2022), 123-144. DOI: 10.17654/0973514322009

This Open Access Article is Licensed under Creative Commons Attribution 4.0 International License

References:

[1] R. PraveenKumar, Medical data processing and prediction of future health condition using sensors data mining techniques and R programming, International Journal of Scientific Research and Engineering Development 3(4) (2020). Available at SSRN: https://ssrn.com/abstract=3686347.
[2] T. I. Dolgikh, D. A. Serbaev, G. V. Chekmarev and T. V. Kadcyna, Experience in developing graphical user interface to R programming language for clinical and experimental data analysis, Kazan Medical Journal 94(5) (2013), 677-681. https://doi.org/10.17816/KMJ1918.
[3] Y. Rimal, S. Gochhait and A. Bisht, Data interpretation and visualization of COVID-19 cases using R programming, Informatics in Medicine Unlocked 26 (2021), 100705. doi: https://doi.org/10.1016/j.imu.2021.100705.
[4] Eva Morales, Nathaly Torres-Castillo and Marta Garaulet, Infancy and childhood obesity grade predicts weight loss in adulthood: the ONTIME study, Nutrients 13(7) (2021), 2132. https://doi.org/10.3390/nu13072132.
[5] James L. Alexander and Nick Powell, SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of gastroenterology inflammatory bowel disease section and IBD clinical research group position statement, Lancet Gastroenterol. Hepatol. 6 (2021), 218-224.
[6] Jonathan Wei Jie Lee, Damian Plichta, Larson Hogstrom, Nynke Z Borren, Helena Lau, Sara M. Gregory, William Tan, Hamed Khalili, Clary Clish, Hera Vlamakis, Ramnik J. Xavie and Ashwin N. Ananthakrishnan, Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease, Clinical and Translational Report 29(8) (2021), 1218-1220.
https://doi.org/10.1016/j.chom.2021.06.019.
[7] Anupam Kumar Singh, Anuraag Jena, Praveen Kumar-M, Vishal Sharm, Shaji Sebastian, Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: a systematic review and meta-analysis, United European Gastroenterol. Journal 9 (2021), 159-176. https://doi.org/10.1177/2050640620972602.
[8] Marko Kumric, Tina Ticinovic Kurir, Dinko Martinovic, Piero Marin Zivkovic and Josko Bozic, Impact of the COVID-19 pandemic on inflammatory bowel disease patients: a review of the current evidence, World Journal of Gastroenterology 27(25) (2021), 3748-3761. 10.3748/wjg.v27.i25.3748.
[9] Mohamed Attauabi, Jakob Seidelin and Johan Burisch, Association between 5 aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology? Medical Journal on Gastroenterology and Hepatology 70 (2021), 2020-2022. doi:10.1136/gutjnl-2021-324397 (gutjnl-2021-324397).